Page last updated: 2024-11-03

ro 31-8220 and Coronary Occlusion

ro 31-8220 has been researched along with Coronary Occlusion in 1 studies

Ro 31-8220: a protein kinase C inhibitor

Coronary Occlusion: Complete blockage of blood flow through one of the CORONARY ARTERIES, usually from CORONARY ATHEROSCLEROSIS.

Research Excerpts

ExcerptRelevanceReference
"We demonstrate that ruboxistaurin administration to a pig model of myocardial infarction-induced heart failure was protective."7.77Inhibition of PKCα/β with ruboxistaurin antagonizes heart failure in pigs after myocardial infarction injury. ( Correll, RN; Hajjar, RJ; Houser, SR; Ishikawa, K; Kawase, Y; Ladage, D; Molkentin, JD; Tilemann, L, 2011)
"We demonstrate that ruboxistaurin administration to a pig model of myocardial infarction-induced heart failure was protective."3.77Inhibition of PKCα/β with ruboxistaurin antagonizes heart failure in pigs after myocardial infarction injury. ( Correll, RN; Hajjar, RJ; Houser, SR; Ishikawa, K; Kawase, Y; Ladage, D; Molkentin, JD; Tilemann, L, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ladage, D1
Tilemann, L1
Ishikawa, K1
Correll, RN1
Kawase, Y1
Houser, SR1
Molkentin, JD1
Hajjar, RJ1

Other Studies

1 other study available for ro 31-8220 and Coronary Occlusion

ArticleYear
Inhibition of PKCα/β with ruboxistaurin antagonizes heart failure in pigs after myocardial infarction injury.
    Circulation research, 2011, Dec-09, Volume: 109, Issue:12

    Topics: Animals; Cardiac Output; Coronary Occlusion; Disease Models, Animal; Dose-Response Relationship, Dru

2011